Navigation Links
Bernstein Liebhard LLP Launches New Transvaginal Mesh Lawsuit Website as Claims Continue to Mount in U.S. Litigations

(PRWEB) December 28, 2013

A new transvaginal mesh lawsuit ( website has been launched by the attorneys at Bernstein Liebhard LLP, who are actively filing claims on behalf of women who may have sustained pelvic mesh injuries.

The Firm’s new site will include vital information regarding the process of filing a case alleging mesh erosion, pain, vaginal scarring, infection, organ perforation and other serious complications, as well as updates in the fast-growing nationwide litigation of vaginal mesh lawsuits. According to court documents, at least 40,000 claims involving this class of devices, which are used in the treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI), are currently pending in federal and state courts throughout the U.S. These lawsuits involve products marketed by such manufacturers as Ethicon Inc., American Medical Systems, Inc., C.R. Bard, Inc., and Boston Scientific Corp.

“As we continue to speak with women who have allegedly been injured as a result of transvaginal mesh, our Firm recognizes the importance of providing a website that educates women about mesh lawsuits,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of dangerous drugs and medical devices. In addition to its new website, the Firm is currently offering free and confidential case evaluations to women who may have been injured as a result of pelvic mesh.

Transvaginal Mesh Lawsuits
The majority of transvaginal mesh lawsuits filed in the U.S. are now pending in separate federal multidistrict litigations established in the U.S. District Court, Southern District of West Virginia. These proceedings include: American Medical Systems (MDL No. 2325), Boston Scientific Corp., (MDL No. 2326); C.R. Bard, Inc., (MDL No. 2187), and Ethicon, Inc. (MDL No. 2327). Jeffrey S. Grand, a partner at Bernstein Liebhard LLP, is actively serving on the Plaintiffs’ Steering Committees for the above four litigations.

Mr. Grand is also serving as Co-Liaison Counsel in two consolidated proceedings established in New Jersey’s Atlantic County Superior Court, where claims involving products from C.R. Bard and Ethicon have been filed. In the C.R. Bard proceeding, court documents issued in December show that over 900 cases have been filed, while nearly 4,600 lawsuits are now pending in the Ethicon litigation. Mr. Grand served on the trial team for the Ethicon proceeding’s first trial, which completed in March 2013 with an $11 million damage award to the Plaintiff, who received a Gynecare pelvic mesh implant. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10)

The number of transvaginal mesh lawsuits has steadily grown over the past five years. In 2008, The U.S. Food and Drug Administration (FDA) issued its first public health alert regarding this class of devices after receiving numerous adverse event reports that detailed such side effects as organ damage, chronic infection and shrinkage. At the time, the potential for these complications to occur was classified as “rare” by the federal agency; a stance it upgraded in 2011 to “not rare” after the number of FDA-filed complaint reports increased steadily over a three-year period.*

Women who may have experienced chronic infection, vaginal scarring or another injury resulting from transvaginal mesh are urged to consider seeking compensation for lost wages, out-of-pocket medical expenses and other damages. Learn more about filing a transvaginal mesh lawsuit by visiting Bernstein Liebhard LLP’s new website. You may also call the following toll-free number to receive a free and confidential case review: 800-511-5092.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pradaxa Lawsuits Mount, as Claims in Federal Multidistrict Litigation Exceed 2,000, Bernstein Liebhard LLP Reports
2. Transvaginal Mesh Lawsuits Move Forward, as Federal Litigations Prep for 2014 Bellwether Trials, Bernstein Liebhard LLP Reports
3. As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Finding that Acetaminophen Combined With Alcohol May Increase Risk for Kidney Damage
4. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order Pertaining to Discovery in Federal Boston Scientific Litigation
5. GranuFlo Lawsuit News: Bernstein Liebhard LLP Notes Filing of New Joint Motion in Federal GranuFlo Recall Litigation
6. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Notes Publication of New Study Questioning Cost, Benefits of Robotic Surgery
7. Bernstein Liebhard LLP Notes Progress in Federal Byetta Lawsuit Litigation, Where More than 160 Claims Have Now Been Filed
8. More Than 430 Cases Now Filed in Federal GranuFlo Lawsuit Litigation, Bernstein Liebhard LLP Continues to Investigate Dialysis Claims
9. Bernstein Liebhard LLP Notes Filing of New Mirena Lawsuit Alleging Spontaneous IUD Migration, other Complications
10. Nearly 900 Cases Now Pending in Federal Biomet Hip Lawsuit Litigation; Federal Judge Sets Deadlines for Bellwether Trial Selection, Bernstein Liebhard LLP Reports
11. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Notes New Da Vinci Robot Recall for Endowrist Instruments
Post Your Comments:
(Date:11/25/2015)... , ... November 25, 2015 , ... On November 10, ... States District Court of Connecticut on behalf of a home health care worker who ... current or former home health care workers employed by Humana, Inc., Humana at Home, ...
(Date:11/25/2015)... ... , ... On November 25, 2015, officials of Narconon Arrowhead , the ... of a new cutting edge recovery program that has been 50 years in the ... alcohol-addicted individuals with the purpose to free addicts from the symptoms and negative behaviors ...
(Date:11/25/2015)... ... , ... SCOTTSDALE, AZ) - Today, Dr. Todd C. ... and non-surgical treatments, announced the expansion of his private practice capabilities with the ... Highly trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Today, ... on our nation’s roadways has dropped below 10,000 for the first time since 2011. ... in 2013. , According to data released by the National Highway Traffic Safety Administration ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... of philanthropic seniors, is resulting in a way for homeless people to have ... Schaumburg have launched a new initiative whereby they are repurposing plastic bags into ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , November 25, 2015 ... due to repeated failure of IVF cycles. After failure ... was totally dejected and had lost all hopes that she would be able ... Indian miracle child conceived after failure of over 15 ... abroad (UK) before they decided to take one last attempt with ...
(Date:11/24/2015)... SAN CARLOS, Calif. , Nov. 24, ... ), a leader in non-invasive genetic testing ... today announced that it will present at ... Conference in New York on Wednesday, December 2, 2015 at 1:00 p.m. ... discuss the Company,s financial results, business activities ...
(Date:11/24/2015)... /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") ... the first patient has been enrolled in ESSA,s Phase ... metastatic castration-resistant prostate cancer ("mCRPC"). the ... the United States and Canada.  ... trial, ESSA intends to demonstrate the safety, tolerability, maximum ...
Breaking Medicine Technology: